Recent COVID-19 pandemic has revealed individual difference in the risk of severity and death; however, its underlying mechanism remains unclear. An accumulating body of evidence has shown that metabolic state affects our immune system. For instance, diabetes and obesity increase the risk of severity of COVID-19, and conversely, treatment with statins ameliorates the risk. The innate immune system is a first line of defense against viral infection, and we found the mechanism of cholesterol metabolism associated with the innate immune response. First, we performed a chemical screening to isolate small chemicals that accelerate antiviral innate immune responses, and found that several statins, which inhibits cholesterol synthesis, augment antiviral innate immune responses. Treatment of cells with statins induced the expression of minor type I interferon genes, such as IFN-ω and IFN-α16, even in uninfected cells in a cell-type specific manner. Small amount of IFN-ω was enough to markedly enhance antiviral innate immune response during viral infection. This augmentation was also observed when cholesterol synthesis was inhibited by knockdown of the HMGCR gene. Our data indicate that intracellular cholesterol metabolism is linked to the expression of minor type I IFNs, leading to the regulation of antiviral innate immune responses.